X-108686096-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_033380.3(COL4A5):c.4282C>T(p.Arg1428Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00085 in 1,208,447 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 340 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_033380.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A5 | NM_033380.3 | c.4282C>T | p.Arg1428Cys | missense_variant | 48/53 | ENST00000328300.11 | NP_203699.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A5 | ENST00000328300.11 | c.4282C>T | p.Arg1428Cys | missense_variant | 48/53 | 1 | NM_033380.3 | ENSP00000331902.7 |
Frequencies
GnomAD3 genomes AF: 0.000351 AC: 39AN: 111085Hom.: 0 Cov.: 23 AF XY: 0.000331 AC XY: 11AN XY: 33281
GnomAD3 exomes AF: 0.000345 AC: 63AN: 182384Hom.: 0 AF XY: 0.000388 AC XY: 26AN XY: 67026
GnomAD4 exome AF: 0.000900 AC: 988AN: 1097309Hom.: 0 Cov.: 30 AF XY: 0.000907 AC XY: 329AN XY: 362753
GnomAD4 genome AF: 0.000351 AC: 39AN: 111138Hom.: 0 Cov.: 23 AF XY: 0.000330 AC XY: 11AN XY: 33344
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 7706490, 9195222) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Uncertain significance, no assertion criteria provided | research | Gharavi Laboratory, Columbia University | Sep 16, 2018 | - - |
X-linked Alport syndrome Benign:3
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 04, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 17, 2022 | - - |
COL4A5-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 05, 2023 | The COL4A5 c.4264C>T variant is predicted to result in the amino acid substitution p.Arg1422Cys. This variant was reported in two individuals with Alport syndrome along with a second potentially pathogenic variant (Guo. 1995. PubMed ID: 7706490; Table S3, Domingo-Gallego. 2022. PubMed ID: 33532864). This variant is reported in 0.067% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including 28 hemizygous individuals (http://gnomad.broadinstitute.org/variant/X-107929326-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at